SEC Form 4 · accession 0001193125-26-326137
Relay Therapeutics, Inc. · RLAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald A Bergstrom
Officer — President, R&D
Period of report
Jul 28, 2026
Accepted (ET)
Jul 30, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001812364
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 28, 2026 | S | 2,237 | $18.61 | D | 407,660 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,012 shares of restricted stock units ("RSUs") on July 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- F2Includes 10,025 shares underlying RSUs.